The goal of this research is to understand the structure-function relationships and mechanisms of action of amino acid decarboxylases, a major class of pyridoxal phosphate (PLP)-dependent enzymes for which relatively little structural information is available. Decarboxylases are important therapeutic targets, generating biogenic amines such as histamine, dopamine, and polyamines. Structural information on decarboxylases and their inhibitor complexes are necessary to understand different PLP enzymes in sufficient detail to aid in the design of drugs targeted against their specific enzymatic activities. The X-ray structure, gene sequence and effector properties of a PLP- dependent ornithine decarboxylase (ODC) have been determined. We propose to use X-ray crystallography, supplemented with the techniques of site- directed mutagenesis and steady state kinetics, to examine the roles of key residues involved in the mechanism of action and effector activation of ODC from L.30a. Structures of inhibitor complexes will answer questions about """"""""closed"""""""" and """"""""open"""""""" forms of ODC and the nature and stereochemistry of catalytic intermediates. X-ray structures and kinetic properties of site-directed mutants will enable the assignment of specific roles to amino acid residues responsible for substrate specificity and binding, catalytic mechanism, GTP effector action, and subunit interactions. Sequence comparisons based on the structure of ODC from L.30a led us to suggest that there are at least two distinct structural families of decarboxylases. X-ray quality crystals have been produced for two examples of second class of decarboxylases, mouse ODC (which is very closely related to the human and trypanosomal ODCs) and biosynthetic arginine decarboxylase (bADC) from E. coli. The X-ray structures of these enzymes will be determined and mechanistic studies similar to those proposed for the ODC from L.30a will be extended to these systems. Crystals of mouse ODC-DFMO (difluoromethyl ornithine), a suicide inhibitor of ODC used in the treatment of African sleeping sickness, have also been obtained. These enzymes represent a new class of highly regulated, therapeutic targets for X-ray structural analysis. They also share a novel model of inactivation resulting from antizyme binding and conditions to produce decarboxylase-antizyme complex crystals will be screened.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM030105-16
Application #
2684734
Study Section
Biophysical Chemistry Study Section (BBCB)
Project Start
1982-02-01
Project End
2000-03-31
Budget Start
1998-04-01
Budget End
2000-03-31
Support Year
16
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Texas Austin
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
City
Austin
State
TX
Country
United States
Zip Code
78712
Almrud, J J; Oliveira, M A; Kern, A D et al. (2000) Crystal structure of human ornithine decarboxylase at 2.1 A resolution: structural insights to antizyme binding. J Mol Biol 295:16-Jul
Stamps, S L; Taylor, A B; Wang, S C et al. (2000) Mechanism of the phenylpyruvate tautomerase activity of macrophage migration inhibitory factor: properties of the P1G, P1A, Y95F, and N97A mutants. Biochemistry 39:9671-8
Knapp, J E; Carroll, D; Lawson, J E et al. (2000) Expression, purification, and structural analysis of the trimeric form of the catalytic domain of the Escherichia coli dihydrolipoamide succinyltransferase. Protein Sci 9:37-48
Vitali, J; Carroll, D; Chaudhry, R G et al. (1999) Three-dimensional structure of the Gly121Tyr dimeric form of ornithine decarboxylase from Lactobacillus 30a. Acta Crystallogr D Biol Crystallogr 55:1978-85
Taylor, A B; Johnson Jr, W H; Czerwinski, R M et al. (1999) Crystal structure of macrophage migration inhibitory factor complexed with (E)-2-fluoro-p-hydroxycinnamate at 1.8 A resolution: implications for enzymatic catalysis and inhibition. Biochemistry 38:7444-52
Kern, A D; Oliveira, M A; Coffino, P et al. (1999) Structure of mammalian ornithine decarboxylase at 1.6 A resolution: stereochemical implications of PLP-dependent amino acid decarboxylases. Structure 7:567-81
Taylor, A B; Czerwinski, R M; Johnson Jr, W H et al. (1998) Crystal structure of 4-oxalocrotonate tautomerase inactivated by 2-oxo-3-pentynoate at 2.4 A resolution: analysis and implications for the mechanism of inactivation and catalysis. Biochemistry 37:14692-700
Kitto, G B; Thomas, P W; Hackert, M L (1998) Evolution of cooperativity in hemoglobins: what can invertebrate hemoglobins tell us? J Exp Zool 282:120-6
Oliveira, M A; Carroll, D; Davidson, L et al. (1997) The GTP effector site of ornithine decarboxylase from Lactobacillus 30a: kinetic and structural characterization. Biochemistry 36:16147-54
Kern, A; Oliveira, M A; Chang, N L et al. (1996) Crystallization of a mammalian ornithine decarboxylase. Proteins 24:266-8

Showing the most recent 10 out of 24 publications